Experience

• 

  FREDsense Technologies

  • Canada
  • Utilities
  • 1 - 100 Employee

  • Research And Development Scientist of Water Toxin Sensors

    • Jan 2023 - Present

  • Cofounder

    • Apr 2014 - Jan 2023

    I have been a part of FREDsense since its inception as an iGEM competition project in the summer of 2011 as the teaching assistant for undergraduate team members.

• 

  BioAro Inc.

  • Calgary, AB

  • Genomics Team Lead

    • Apr 2022 - Jan 2023
    • Calgary, AB

    I am thrilled to lead a talented team of scientists in developing a private genomic testing service in Calgary, Alberta. My main focus within the group is laboratory operation and assay development in genomic next generation sequencing.

• 

  CardiAI.Inc

  • Calgary, Alberta, Canada

  • Research and Development Project Manager and Clinical Lab Manager

    • Jul 2020 - Jan 2023
    • Calgary, Alberta, Canada

• 

  University of Calgary

  • Canada
  • Higher Education
  • 700 & Above Employee

  • Post-doctoral Fellow

    • Jun 2015 - Jul 2020

    I work with a team that is developing electrochemical biosensors. My main project is to create a sensor for Δ9-tetrahydrocannabinol (THC) of cannabis. The sensor we are designing will be a saliva-based sensor to detect impairment such as being a road-side sensor. However this sensor could be adapted to applications that involve any analysis of THC such as measuring the drug potency of edibles. We have made significant progress in this project and have a paper describing electrochemical drug detection in Electrochimica Acta.I am also working with the Canadian military to develop sensors that detect airborne pathogens.

  • PHD

    • Sep 2008 - Jun 2015

    Cancer is a disease of the genome that shares characteristics or hallmarks that augment its pathogenicity. I have researched mechanisms that contribute to the cancer hallmarks of metastasis and genome instability using mammalian and yeast model systems. I worked with budding yeast to study replication and DNA damage. I characterized the function of the HAT complex NuA4 in translesion synthesis of DNA damage tolerance for my Ph.D. with Dr. Jennifer Cobb.While researching oncogenic mechanisms, I had become interested in utilizing electrochemical techniques to create devices that facilitate disease and toxin detection. This interest has led to transitioning to electrochemical biosensors with Dr. Viola Birss to develop electrochemistry techniques to resolve nanoscale biological interactions for the purposes of pathogen protection. Work with Dr. Birss also enables me to learn electrochemical techniques that are essential to the development of sensors for FREDsense.